Online citations, reference lists, and bibliographies.

Drug Delivery To Skin By Needle-Free Injector

H. Todo
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
The transdermal drug delivery system (TDDS) has several advantages including the avoidance of the hepatic first-pass effect of drugs, long-acting sustained release of drugs, improved patient compliance, and painless administration. However, traditional TDDS has a limitation for the molecular size of drugs (<500 Da). Thus, TDDS formulations are not suitable for administration of high molecular hydrophilic drugs, such as proteins and vaccines. To overcome this problem, physicochemical methods, such as electroporation, microneedle, and needle-free injection (NFI), are becoming popular to increase skin permeation of mal-absorptive drugs. Among these techniques, NFIs have been investigated as an administration device not only for high molecular weight compounds like insulin and human-growth hormone, but also for vaccine and gene delivery. Currently biotechnology-derived medications are the leading edge of medical treatment and many biopharmaceuticals have dominated the top 10 used agents in the global market. In the near feature, development of self-administered injectable biopharmaceuticals associated with NFI or a combination of NFI and new transdermal drug innovative technologies will be needed to be able to incorporate and used into normal routines within patients’ homes and work places.
This paper references
Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model.
Jun-ichi Imoto (2005)
Jet-Injected Insulin Is Associated With Decreased Antibody Production and Postprandial Glucose Variability When Compared With Needle-Injected Insulin in Gestational Diabetic Women
L. Jovanovic-Peterson (1993)
No Effect of the Novel Antidiabetic Agent Nateglinide on the Pharmacokinetics and Anticoagulant Properties of Warfarin in Healthy Volunteers
D. Anderson (2002)
Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle injection in patients with insulin-dependent diabetes mellitus.
G. Pehling (1984)
Risks of jet injection of insulin in children
G. Theintz (2005)
Microneedles for transdermal drug delivery.
M. Prausnitz (2004)
Blood glucose and free insulin levels after the administration of insulin by conventional syringe or jet injector in insulin treated type 2 diabetics.
G. Kerum (1987)
Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology
E. Engwerda (2011)
Dynamic control of needle-free jet injection.
J. Stachowiak (2009)
Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.
D. Yoshida (2007)
Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power.
Joy Schramm-Baxter (2004)
The 500 Dalton rule for the skin penetration of chemical compounds and drugs
J. Bos (2000)
Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously.
D. Grosenbaugh (2004)
Analysis of data on the medicament release from ointments.
W. Higuchi (1962)
Pharmacokinetics and Pharmacodynamics of a New Formulation of Recombinant Human Growth Hormone Administered by ZomaJet 2 Vision, a New Needle‐Free Device, Compared to Subcutaneous Administration Using a Conventional Syringe
H. Agersø (2002)
Effect of vasoactive agents on the dermatopharmacokinetics and systemic disposition of model compounds, salicylate and FITC-dextran 4 kDa, following intracutaneous injection of the compounds.
D. Yoshida (2008)
Jet-induced skin puncture and its impact on needle-free jet injections: experimental studies and a predictive model.
Joy Baxter (2005)
Transdermal Drug Delivery by Jet Injectors: Energetics of Jet Formation and Penetration
J. Schramm (2004)
Effect of molecular weight on the dermatopharmacokinetics and systemic disposition of drugs after intracutaneous injection.
D. Yoshida (2008)
Intradermal vaccination for Mycoplasma hyopneumoniae
G. Jones (2005)
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors.
L. Jackson (2001)
A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs
P. L. Ritger (1987)
Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector.
J. Simon (2011)
Mechanism of the synergic effects of calcium chloride and electroporation on the in vitro enhanced skin permeation of drugs.
Y. Tokudome (2004)
Fundamental investigation of a novel drug delivery system, a transdermal delivery system with jet injection
N. Inoue (1996)
Pharmacokinetics of recombinant human growth hormone administered by™ 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle
C. Brearley (2007)
Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial
L. Mcallister (2014)
Hepatitis A vaccine administration: comparison between jet-injector and needle injection.
J. Williams (2000)
Pharmacokinetics and pharmacodynamics of a single dose of recombinant human growth hormone after subcutaneous administration by jet-injection: comparison with conventional needle-injection
A. Verhagen (1995)
Heterogeneity of human adipose blood flow
D. Levitt (2007)
Piezoelectric control of needle-free transdermal drug delivery.
J. Stachowiak (2007)
Role of neutrophils in induction of acute inflammation in T‐cell‐mediated immune dermatosis, psoriasis: A neutrophil‐associated inflammation‐boosting loop
T. Terui (2000)
Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets
A. Arora (2007)
Therapeutic transdermal drug innovation from 2000 to 2014: current status and outlook.
J. Walter (2015)

Semantic Scholar Logo Some data provided by SemanticScholar